Home
News
Details

Analyst suggests 7709 HK may sell 200,000 SK Hynix shares at Monday's KRX open.

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
An on-chain data analyst on X, known as degentrading, noted that 7709.HK may sell 200,000 SK Hynix shares at Monday’s KRX open, representing 40% of daily volume. This move is driven by rebalancing requirements linked to the 2x leveraged product issued by CSOP. Open interest levels suggest potential volatility, as selling pressure could concentrate at the open due to time zone disparities. The data is based on personal calculations, and the analyst invites community feedback.
ME AI message: AI investor degentrading posted on X that 7709 HK appears to need to sell 2 million shares of SK Hynix when the Korean market opens on Monday, equivalent to 40% of the daily volume. The post notes that this data is based on personal analysis and encourages community feedback for corrections. Note: 7709.HK is CSOP’s daily (2x) leveraged product tracking SK Hynix (CSOP 2x Long SK Hynix). Rebalancing typically occurs at the close of the Korea Exchange (KRX), but due to time zone differences and potential Monday opening gaps, selling pressure may concentrate in early Monday trading. This data is an analyst’s estimate based on publicly available market information. (Source: ODAILY)
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.